Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Monkeypox outbreak 2022: What we know so far and its potential drug targets and management strategies
Ali A. Rabaan, Abdul Hawil Abas, Trina Ekawati Tallei, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Progress and prospects on vaccine development against monkeypox infection
Mohamed J. Saadh, Tahmineh Ghadimkhani, Narges Soltani, et al.
Microbial Pathogenesis (2023) Vol. 180, pp. 106156-106156
Open Access | Times Cited: 42
Mpox: An Overview of Pathogenesis, Diagnosis, and Public Health Implications
Francesco Branda, Chiara Romano, Massimo Ciccozzi, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 8, pp. 2234-2234
Open Access | Times Cited: 26
Molecular docking of monkeypox (mpox) virus proteinase with FDA approved lead molecules
M.Valan Arasu, P. Vijayaragavan, Sumitha Purushothaman, et al.
Journal of Infection and Public Health (2023) Vol. 16, Iss. 5, pp. 784-791
Open Access | Times Cited: 19
Hyper-parameter tuned deep learning approach for effective human monkeypox disease detection
Neeraj Dahiya, Yogesh Kumar Sharma, Uma Rani, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 18
A stochastic SIRD model with imperfect immunity for the evaluation of epidemics
Vasileios E. Papageorgiou, George Tsaklidis
Applied Mathematical Modelling (2023) Vol. 124, pp. 768-790
Closed Access | Times Cited: 16
Antivirals against Monkeypox (Mpox) in Humans: An Updated Narrative Review
Giuseppe Bruno, Giovanni Battista Buccoliero
Life (2023) Vol. 13, Iss. 10, pp. 1969-1969
Open Access | Times Cited: 16
Identifying potential monkeypox virus inhibitors: an in silico study targeting the A42R protein
Carolyn Ashley, Emmanuel Broni, Chanyah M. Wood, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 7
The discovery of novel antivirals for the treatment of mpox: is drug repurposing the answer?
Ahmed A. Ezat, Jameel M. Abduljalil, Ahmed M. Elghareib, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 5, pp. 551-561
Closed Access | Times Cited: 15
Monkeypox: A comprehensive review on mutation, transmission, pathophysiology, and therapeutics
Somenath Dutta, Rohan Ghosh, I. Dasgupta, et al.
International Immunopharmacology (2024) Vol. 146, pp. 113813-113813
Closed Access | Times Cited: 5
Mitigation approaches of monkeypox outbreaks in developing countries
Misganu Yadesa Tesema
Discover Viruses. (2025) Vol. 2, Iss. 1
Open Access
Computational investigation of antiviral peptide interactions with Mpox DNA polymerase
Harshit Tiwari, Ashal Ilyas, Pankaj Kumar, et al.
In Silico Pharmacology (2025) Vol. 13, Iss. 1
Closed Access
VP37 Protein Inhibitors for Mpox Treatment: Highlights on Recent Advances, Patent Literature, and Future Directions
Shuaibu Abdullahi Hudu, Ahmed Subeh Alshrari, Aiman Al-Qtaitat, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1106-1106
Open Access | Times Cited: 12
Pharmacological treatment and vaccines in monkeypox virus: a narrative review and bibliometric analysis
Muhammad Aaqib Shamim, Prakasini Satapathy, Bijaya Kumar Padhi, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Strengthening Africa’s response to Mpox (monkeypox): insights from historical outbreaks and the present global spread
David B. Olawade, Ojima Z. Wada, Sandra Chinaza Fidelis, et al.
Science in One Health (2024) Vol. 3, pp. 100085-100085
Open Access | Times Cited: 4
Novel drug targets for monkeypox: From viral to host proteins
Zhaozhong Zhu, Qin Sun, Yilun Xu, et al.
Infectious Medicine (2025) Vol. 4, Iss. 1, pp. 100165-100165
Open Access
Monkeypox: Origin, Transmission, Clinical Manifestations, Prevention, and Therapeutic Options
Sajal Kumar Halder, Arafin Sultana, Mahbubul Kabir Himel, et al.
Interdisciplinary Perspectives on Infectious Diseases (2025) Vol. 2025, Iss. 1
Open Access
Elucidating the suppressive mechanism of four inhibitors on VP39 and unique conformational changes with protein in mode 2
Pengfei Gao, Song Luo, Jinxin Liu, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2025) Vol. 334, pp. 125917-125917
Closed Access
Efficient monkeypox detection using hybrid lightweight CNN architectures and optimized SVM with grid search on imbalanced data
Dilber Çetintaş
Signal Image and Video Processing (2025) Vol. 19, Iss. 4
Closed Access
Advancing the understanding and management of Mpox: insights into epidemiology, disease pathways, prevention, and therapeutic strategies
Rima Hajjo, Osama H. Abusara, Dima A. Sabbah, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Repurposing of the antibiotic nitroxoline for the treatment of mpox
Denisa Bojková, Nadja Zöller, Manuela Tietgen, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Open Access | Times Cited: 9
Machine learning and classical MD simulation to identify inhibitors against the P37 envelope protein of monkeypox virus
Madhusmita Rout, Suchanda Dey, Sarbani Mishra, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 8, pp. 3935-3948
Closed Access | Times Cited: 7
Multifaceted mutational immunotherapeutic approach to design therapeutic mAbs to combat monkeypox disease via integrated screening algorithms and antibody engineering
Satyendra Singh, Abhishek Rao, Anshuman Mishra, et al.
Molecular Systems Design & Engineering (2023) Vol. 8, Iss. 10, pp. 1301-1318
Closed Access | Times Cited: 7
Tepotinib and tivantinib as potential inhibitors for the serine/threonine kinase of the mpox virus: insights from structural bioinformatics analysis
Jameel M. Abduljalil, Abdo A. Elfiky, Maha AlKhazindar
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-11
Closed Access | Times Cited: 2
The global patent landscape of emerging infectious disease monkeypox
Yuanqi Cai, Xiaoming Zhang, Kuixing Zhang, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Molecular and phylogenetic characterization of the monkeypox outbreak in the South of Spain
Carlos S. Casimiro‐Soriguer, Javier Perez‐Florido, M. Fernanda Lara, et al.
Health Science Reports (2024) Vol. 7, Iss. 3
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top